Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Bain Capital Private Equity proposed to buy the remaining shares of Surgery Partners, an ambulatory surgery center provider in which the private equity firm already has a 39% stake. Under the ...

BizCare Benefits, a company that says it has backing from Bain Capital, is ramping up ICHRA operations by providing ICHRA ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.

(Reuters) -Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on ...

Ltd. entered the bidding frenzy for Insignia Financial Ltd., joining Bain Capital and CC Capital Partners with an offer for ...

SYDNEY—Insignia Financial on Monday said Bain Capital has matched a US$1.8 billion takeover offer by CC Capital Partners, intensifying a tussle for control of the Australian wealth manager.

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...